Cyrus K Becker

This inventor holds 48 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Corsair Pharma, Inc., Aryx Therapeutics, Inc., Syntex (u.s.a.) Inc.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cyrus K Becker. Retrieved from https://idiyas.com/inventor/cyrus-k-becker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 48 (Patent Applications = 7)

% Patents Active = 81.3

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 3.3

ph-index = 15

Forward Citations = 484(Granted Patents)

Location History:

Menlo Park, CA (US) (2003 - 2006)
San Francisco, CA (US) (2003 - 2007)
Fremont, CA (US) (2009 - 2024)
Pleasanton, CA (US) (2017 - 2024)

Company Filing History:

Aryx Therapeutics, Inc.

Panorama Research Inc.

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Treprostinil Derivatives

CNS Disorders

Coagulation Disorders

Aminoadamantyl Nitrate

Stereoisomeric Compounds

5-HT3 Antagonists

Antiarrhythmic Precursors

Gastroesophageal Reflux Disease

Halogenated Esters

Coumarin Derivatives

Dibenzo[b,f][1,4]oxazapine

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12643847 - Treprostinil derivatives and compositions and uses thereof (2026-06-02),

2. 12365663 - Treprostinil derivative compounds and methods of using same (2025-07-22),

3. 12071392 - Aminoadamantyl nitrate compounds and their use to treat CNS disorders (2024-08-27),

4. 11958822 - Treprostinil derivative compounds and methods of using same (2024-04-16),

5. 11866402 - Treprostinil derivatives and compositions and uses thereof (2024-01-09),

6. 11802105 - Treprostinil derivatives and compositions and uses thereof (2023-10-31),

7. 11505535 - Treprostinil derivative compounds and methods of using same (2022-11-22),

8. 11447442 - Aminoadamantyl nitrate compounds and their use to treat CNS disorders (2022-09-20),

9. 11407707 - Treprostinil derivatives and compositions and uses thereof (2022-08-09),

10. 11339139 - Treprostinil derivative compounds and methods of using same (2022-05-24),

11. 11046666 - Treprostinil derivative compounds and methods of using same (2021-06-29),

12. 11034645 - Treprostinil derivatives and compositions and uses thereof (2021-06-15),

13. 10988435 - Treprostinil derivatives and compositions and uses thereof (2021-04-27),

14. 10759733 - Treprostinil derivatives and compositions and uses thereof (2020-09-01),

15. 10752605 - Treprostinil derivative compounds and methods of using same (2020-08-25),

Title: **Cyrus K. Becker: Innovating Treatments for Pulmonary Hypertension**

Introduction

Cyrus K. Becker is a prolific inventor based in Fremont, California. With an impressive portfolio of 45 patents, he has made significant contributions to the field of medicinal chemistry, particularly in treatments for pulmonary hypertension.

Latest Patents

Among his most recent innovations are patents regarding treprostinil derivative compounds and methods of using them. These compounds are represented by specific formulae, including pro-drugs for treprostinil and prostacyclin analogs. They are designed to treat conditions like pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The chemical structures of these compounds can be modified to suit various treatment dosages, and applications may include transdermal delivery methods. Additionally, he has developed treprostinil derivatives that can act as prodrugs, broadening the scope for treating any conditions responsive to treprostinil.

Career Highlights

Cyrus has made his mark in the pharmaceutical industry while working with leading companies. Notably, he has been associated with Corsair Pharma Inc. and Aryx Therapeutics Inc., where his innovative approaches to drug development have paved the way for new therapeutic solutions.

Collaborations

Collaboration has been a key aspect of his career. Cyrus has worked closely with notable professionals in the field, including Xiaoming Zhang and Meenakshi S. Venkatraman. Together, they have endeavored to explore new frontiers in medical treatments.

Conclusion

Cyrus K. Becker's inventive spirit and dedication to research have established him as a significant figure in the field of pharmaceuticals. His advancements in the treatment of pulmonary hypertension and innovative drug delivery methods underscore the impact of his work on patient care and outcomes.

Profile summary based on public USPTO records.